Daniel Dauch

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Replacement Therapy

Tyrosine Kinase

Cross Sectional

Dna Damage Response

Top Venues

Journal of medicinal chemistry

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Moritz Schwarz, Maksym Kurkunov, Florian Wittlinger, Ramona Rudalska, Guiqun Wang, Martin Peter Schwalm, Alexander Rasch, Benedikt Wagner, Stefan A Laufer, Stefan Knapp, Daniel Dauch, Alexander Titz
Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on S N Ar Electrophiles. Journal of medicinal chemistry (2024)
Moritz Schwarz, Maksym Kurkunov, Florian Wittlinger, Ramona Rudalska, Guiqun Wang, Martin Peter Schwalm, Alexander Rasch, Benedikt Wagner, Stefan A Laufer, Stefan Knapp, Daniel Dauch, Alexander Titz
Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on S N Ar Electrophiles. Journal of medicinal chemistry 67 (8) (2024)
Teodor Dimitrov, Athina Anastasia Moschopoulou, Lennart Seidel, Thales Kronenberger, Mark Kudolo, Antti Poso, Christian Geibel, Pascal Wölffing, Daniel Dauch, Lars Zender, Dieter Schollmeyer, Jürgen Bajorath, Michael Forster, Stefan A Laufer
Design and Optimization of Novel Benzimidazole- and Imidazo[4,5- b ]pyridine-Based ATM Kinase Inhibitors with Subnanomolar Activities. Journal of medicinal chemistry (2023)
Ramona Rudalska, Lars Zender, Daniel Dauch
Exploiting lipotoxicity for the treatment of liver cancer. British journal of cancer 125 (11) (2021)
Ramona Rudalska, Jule Harbig, Marteinn T Snaebjornsson, Sabrina Klotz, Stefan Zwirner, Liudmyla Taranets, Florian Heinzmann, Thales Kronenberger, Michael Forster, Wei Cui, Luana D'Artista, Elias Einig, Martina Hinterleitner, Werner Schmitz, Agata Dylawerska, Tae-Won Kang, Antti Poso, Mathias T Rosenfeldt, Nisar P Malek, Michael Bitzer, Stefan Laufer, Bernd J Pichler, Nikita Popov, Almut Schulze, Lars Zender, Daniel Dauch
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer. Nature cancer 2 (2) (2021)